Thermo Fisher Buys Clario Holdings for $8.88B

Thermo Fisher Scientific agreed to buy Clario Holdings from a shareholder group led by Astorg Asset Management for $8.88 billion.

“Thermo Fisher Scientific Inc. agreed to buy clinical trial data solutions company Clario Holdings Inc. from a shareholder group led by Astorg Asset Management SARL”

Signals are extracted from public coverage and print archives and pinned to a verbatim quote, presented as reported by their sources; naming a company in a signal is not an accusation against it. The verified mark denotes a high-confidence, corroborated signal. See our methodology and legal notes.